Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,035 | -25,382 | -3,308 | -25,694 | -1,608 |
| Depreciation Amortization | 88 | 7 | 504 | 5,003 | 59 |
| Other Working Capital | -500 | -262 | 4,479 | 360 | 22 |
| Other Operating Activity | 3,814 | 21,976 | -3,917 | 14,142 | 907 |
| Operating Cash Flow | $-8,633 | $-3,661 | $-2,242 | $-6,189 | $-621 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,592 | -13 | N/A | -31 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -50 | 0 |
| Investing Cash Flow | $-1,592 | $-13 | $N/A | $-81 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 311 | 1,481 | 4,615 | N/A |
| Common Stock Issued | 3,222 | 7,126 | 250 | 873 | 1,910 |
| Other Financing Activity | 32,240 | 15,909 | 0 | 0 | -5 |
| Financing Cash Flow | $35,462 | $23,346 | $1,731 | $5,488 | $1,905 |
| Beginning Cash Position | 19,672 | N/A | 510 | 1,293 | 8 |
| End Cash Position | 44,909 | 19,672 | N/A | 510 | 1,293 |
| Net Cash Flow | $25,237 | $19,672 | $-510 | $-782 | $1,284 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,633 | -3,661 | -2,242 | -6,189 | -621 |
| Capital Expenditure | -1,592 | -13 | N/A | -31 | N/A |
| Free Cash Flow | -10,225 | -3,674 | -2,242 | -6,220 | -621 |